Evidence map›Paper›PMID 11077446›Full record

ArticleOncogene2000

PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition.

K Komatsu, W Wharton, H Hang, C Wu, S Singh, H B Lieberman, W J Pledger, H G Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

K KomatsuDrug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida, FL 33612, USA.
W Wharton
H Hang
C Wu
S Singh
H B Lieberman
W J Pledger
H G Wang
Moffitt Cancer Center · USColumbia University · USIDEX Corporation (United States) · US

Funding

POSTTRANSLATIONAL MODIFICATIONS OF BADR01CA082197 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI WANG, HONG-GANG · 1999 to 2015
$3.3M
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSIONR01GM052493 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIEBERMAN, HOWARD B · 1995 to 2006
$2.8M
GROWTH FACTOR REGULATION OF P27KIPL EXPRESSIONR01CA072694 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI PLEDGER, WARREN JACKSON · 1997 to 2000
$203k
NCI NIH HHS CA72694NCI NIH HHS CA82197NIGMS NIH HHS GM52493
6 · The paper itself

Abstract

The hHus1 and several hRad proteins are involved in the control of DNA integrity checkpoints, although the mechanisms underlying these processes are unknown. Using a yeast two-hybrid system to detect protein-protein interactions, we found that human proliferating cell nuclear antigen (PCNA), a protein known to function in both DNA replication and repair, interacts with the human checkpoint-related protein Hus1 (hHus1). In human skin fibroblast cells, exposure to ionizing radiation of hydroxyurea triggers translocation of hHus1 from the cytosol to the nucleus, where it associates with PCNA as well as another checkpoint protein, hRad9. This nuclear translocation and the complex formation or hHus1 with PCNA and hRad9 correlate closely with changes in cell cycle distribution in response to radiation exposure. These results suggest that this multi-protein complex may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.

Indexed as

DNA DamageDNA ReplicationActive Transport, Cell NucleusCell CycleCell Cycle ProteinsCell DivisionCell LineCell NucleusCells, CulturedCytoplasmFibroblastsGamma RaysHumansHydroxyureaMacromolecular SubstancesProliferating Cell Nuclear AntigenCell Cycle Proteinshus1 protein, S pombeHydroxyureaMacromolecular SubstancesProliferating Cell Nuclear Antigenrad9 proteinSchizosaccharomyces pombe Proteins

Identifiers

PMID11077446
OpenAlexW2078341540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.